¶ Tested on humans for the first time, trifluoroethyl vinyl ether turned out to be a promising new anesthetic. Product of 15 years research by Dr. John C. Krantz Jr., Johns Hopkins pharmacology professor, the fluorinated ether puts a patient to sleep in 27 seconds (a standard ether takes up to five minutes), has an agreeable odor and a high boiling point that should make it useful in warm climates. Biggest advantage: not readily combustible, it will reduce the danger of disastrous operating-room explosions.
¶ Strong Cobb & Co. of Cleveland announced a new...
To continue reading:
or
Log-In